[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H 2K1", "country": "Canada", "website": "https://www.psyence.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 49, "title": "Co-Founder & Executive Chairman", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 111282, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "title": "CEO & Director", "fiscalYear": 2023, "totalPay": 252239, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law", "age": 51, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick  Corden-Lloyd", "age": 43, "title": "CFO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 111282, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Budden", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary-Elizabeth  Gifford", "title": "Executive Vice President for Public Policy & Global Impact", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Clive  Ward-Able BPharm, M.D.", "title": "Medical Director and Head of R&D and Early Commercialization", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.06, "open": 0.04, "dayLow": 0.03235, "dayHigh": 0.04, "regularMarketPreviousClose": 0.06, "regularMarketOpen": 0.04, "regularMarketDayLow": 0.03235, "regularMarketDayHigh": 0.04, "beta": 0.285, "volume": 32000, "regularMarketVolume": 32000, "averageVolume": 10259, "averageVolume10days": 7862, "averageDailyVolume10Day": 7862, "marketCap": 6625991, "fiftyTwoWeekLow": 0.014, "fiftyTwoWeekHigh": 0.8921, "fiftyDayAverage": 0.051022, "twoHundredDayAverage": 0.0993793, "currency": "USD", "enterpriseValue": 4629402, "floatShares": 131495355, "sharesOutstanding": 137438000, "heldPercentInsiders": 0.03881, "impliedSharesOutstanding": 204822000, "bookValue": -0.002, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -6619167, "trailingEps": -0.04, "enterpriseToEbitda": -0.721, "52WeekChange": -0.73041666, "SandP52WeekChange": 0.21733451, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PSYGF", "underlyingSymbol": "PSYGF", "shortName": "PSYENCE GROUP INC", "longName": "Psyence Group Inc.", "firstTradeDateEpochUtc": 1654003800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "5781b508-51cf-39d5-8fbe-9a540a0551c1", "messageBoardId": "finmb_682094975", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.03235, "recommendationKey": "none", "totalCash": 856496, "totalCashPerShare": 0.006, "ebitda": -6423402, "totalDebt": 1039773, "quickRatio": 0.374, "currentRatio": 0.404, "returnOnAssets": -1.7832401, "returnOnEquity": -31.19291, "freeCashflow": -2688739, "operatingCashflow": -5432964, "financialCurrency": "CAD", "trailingPegRatio": null}]